Results 291 to 300 of about 39,808 (354)
Some of the next articles are maybe not open access.
The latest consensus on antiemetics
Current Opinion in Oncology, 2018Purpose of review The present review summarizes and discuss the most recent updated antiemetic consensus. Recent findings Two new neurokinin (NK)1-receptor antagonists, netupitant and rolapitant, have been approved by the Food and Drug Administration and
J. Herrstedt
semanticscholar +5 more sources
Estimating the physicochemical properties of antiemetics using degree-based topological descriptors
Molecular Physics, 2023Antiemetics are medications that are used to treat or prevent vomiting or nausea. These two common symptoms are the results of different conditions that include procedures, therapies, and medications.
Zhi-hao Hui +3 more
semanticscholar +1 more source
Antiemetics: ASCO Guideline Update.
Journal of Clinical Oncology, 2020PURPOSE To update the guideline to include new anticancer agents, antiemetics, and antiemetic regimens and to provide recommendations on the use of dexamethasone as a prophylactic antiemetic in patients receiving checkpoint inhibitors (CPIs).
P. Hesketh +16 more
semanticscholar +1 more source
Antiemetics: types, actions and uses.
British journal of hospital medicine, 2020Nausea and vomiting are common symptoms in the hospital setting, with numerous causes. Common precipitants leading to or complicating inpatient hospital admissions include nausea and vomiting secondary to drugs, gastrointestinal disturbances, metabolic ...
M. Dulay, Jasbir S Dulay
semanticscholar +1 more source
Critical Reviews in Oncology/Hematology, 2002
The emetogenic potential of cancer chemotherapeutic agents varies according to the agent employed. Among the highly emetogenic agents, cisplatin has been the most studied. As for emesis induced by cisplatin, an optimal antiemetic schedule is effective in 70-90% of cases of acute emesis, in 60% of cases of delayed emesis, whereas acute emesis induced by
L. Licitra, S. Spinazzé, F. Roila
openaire +3 more sources
The emetogenic potential of cancer chemotherapeutic agents varies according to the agent employed. Among the highly emetogenic agents, cisplatin has been the most studied. As for emesis induced by cisplatin, an optimal antiemetic schedule is effective in 70-90% of cases of acute emesis, in 60% of cases of delayed emesis, whereas acute emesis induced by
L. Licitra, S. Spinazzé, F. Roila
openaire +3 more sources
Current Opinion in Anaesthesiology, 2002
Numerous studies about postoperative nausea and vomiting management are available and meta-analyses have helped to define the appropriate doses of the effective drugs. Almost all recent papers include some economical considerations. In order to rationalize the therapeutic protocols, strategies including systematic prophylaxis, treatment of established ...
Anne-Marie Diemunsch, Pierre Diemunsch
openaire +3 more sources
Numerous studies about postoperative nausea and vomiting management are available and meta-analyses have helped to define the appropriate doses of the effective drugs. Almost all recent papers include some economical considerations. In order to rationalize the therapeutic protocols, strategies including systematic prophylaxis, treatment of established ...
Anne-Marie Diemunsch, Pierre Diemunsch
openaire +3 more sources
Randomized trial of acupuncture with antiemetics for reducing postoperative nausea in children
Acta Anaesthesiologica Scandinavica, 2018Postoperative nausea and vomiting (PONV) is common after tonsillectomy in children. There is evidence that perioperative acupuncture at the pericardium 6 (P6) point is effective for preventing PONV in adults.
C. S. Martin +5 more
semanticscholar +1 more source
Methodology of Antiemetic Trials [PDF]
Drugs, 1992 Progress in antiemetic research dictates that clinical trials of antiemetic agents be conducted according to guidelines for Good Clinical Practice, as follows. Studies must be of a prospective, parallel-group design in which the new treatment is compared with the existing best available treatment, after optimal dosage schedules for each have been ...
J. Gordon McVie, Karel M. de Bruijn
openaire +2 more sources
Metoclopramide as an Antiemetic
Annals of Internal Medicine, 1981Excerpt To the editor: We read with interest the review by Seigel and Longo (1) on the control of chemotherapy-induced emesis.
Jonathan E. McDermed, Stephen B. Strum
openaire +3 more sources
Current Opinion in Oncology, 1997
In the past few years a combination of a 5-HT3 receptor antagonist plus dexamethasone has been shown to be the most efficacious antiemetic prophylaxis of acute emesis induced by cisplatin and moderately emetogenic chemotherapy. In the prevention of cisplatin-induced delayed emesis oral metoclopramide or ondansetron, both combined with dexamethasone ...
F, Roila, A, Del Favero
openaire +2 more sources
In the past few years a combination of a 5-HT3 receptor antagonist plus dexamethasone has been shown to be the most efficacious antiemetic prophylaxis of acute emesis induced by cisplatin and moderately emetogenic chemotherapy. In the prevention of cisplatin-induced delayed emesis oral metoclopramide or ondansetron, both combined with dexamethasone ...
F, Roila, A, Del Favero
openaire +2 more sources